Clinical Trials Directory

Trials / Completed

CompletedNCT01065649

Effect of Nortriptyline in Cortical Representation of Heartburn in Nonerosive Reflux Disease (NERD) Patients

Effect of Nortriptyline in the Cortical Representation of Heartburn in Patients With Nonerosive Reflux Disease

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Universidade de Passo Fundo · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients with nonerosive reflux disease (NERD) are less responsive to standard treatment with proton pump inhibitors. The hypothesis of this study was that nortriptyline in analgesic doses may decrease heartburn perception and its corresponding cortical activity measured by magnetic resonance image. Therefore, the aim of this study was to assess the cortical representation of heartburn in patients with NERD under treatment with nortriptyline and placebo.

Conditions

Interventions

TypeNameDescription
DRUGNortriptylineIt will be administered per oral 10 mg a day in the first 7 days and then 25 mg a day in the last 14 days
DRUGPlacebo armPlacebo per oral for 21 days, equal to nortriptyline

Timeline

Start date
2010-01-01
Primary completion
2010-06-01
Completion
2010-06-01
First posted
2010-02-09
Last updated
2012-07-17

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01065649. Inclusion in this directory is not an endorsement.

Effect of Nortriptyline in Cortical Representation of Heartburn in Nonerosive Reflux Disease (NERD) Patients (NCT01065649) · Clinical Trials Directory